Primary experimental recordPositive observation

PMC12936117::ACT037658

M104

Evidence text

Paper-level observation

Cells treated with 200 µg/mL of peptide M104 for 24 h maintained a mean cell viability of 99.6%, which was not statistically different from the untreated control (p-value > 0.05).

textConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Cytotoxic

Measure

cell_viability

Comparator

Raw observation

99.6%

Normalized measurement

=99.6%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

HDFa

Assay method

MTT assay

Sequence

MEAFIVSAFKHQAEGFKLHYK

Standardization

ready simple

Source publication

Enhanced meropenem activity by a microbiome derived peptide targeting oxacillinase 48 carbapenemase in carbapenem resistant Klebsiella pneumoniae isolates.

Scientific Reports · 2026

DOI 10.1038/s41598-026-37644-2 PMC12936117

Parent mention

Related peptide identities

PEPDIA-PLP-001978

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.